Endoscopic vessel harvesting (EVH) devices enable less-invasive harvesting of vessels for use in coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting, and avoid significant pain and discomfort for patients, the two companies said.
Andre-Michel Ballester, CEO of Sorin Group, said: “After conclusion in 2008 of our divestiture program, this transaction is a first step towards reinforcing our leading cardiac surgery franchises.
“This acquisition will be particularly exciting for Sorin Group’s US business as it will reinforce our product offering and consolidate our position as the leading provider of innovative solutions for the cardiac surgery clinical community.”